PTPA and brain ischemia: In this study, we developed a small interfering peptide that inhibits the interaction of GABAB receptors with PP2A to analyze in more detail the trafficking pathways affected by PP2A and to explore the therapeutic potential of specifically interfering with the GABAB receptor/PP2A interaction using cerebral ischemia as a model for a severely disturbed excitation/inhibition balance.